Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.01 per share
-
Shares outstanding
-
183,255,226
-
Total 13F shares
-
108,535,070
-
Share change
-
-9,219,216
-
Total reported value
-
$620,478,626
-
Put/Call ratio
-
29%
-
Price per share
-
$5.72
-
Number of holders
-
176
-
Value change
-
-$95,435,236
-
Number of buys
-
90
-
Number of sells
-
78
Institutional Holders of HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) as of Q1 2022
As of 31 Mar 2022 HERON THERAPEUTICS, INC. /DE/ - Common Stock, par value $0.01 per share (HRTX) had 176 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 108,535,070 shares of stock of the company.
Largest 10 holders included STATE STREET CORP, FRANKLIN RESOURCES INC, VANGUARD GROUP INC, BlackRock Inc., BAKER BROS. ADVISORS LP, ArrowMark Colorado Holdings LLC, JPMORGAN CHASE & CO, TANG CAPITAL MANAGEMENT LLC, PFM Health Sciences, LP, and PALISADE CAPITAL MANAGEMENT LLC/NJ.
This table shows 176 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.